Agios Pharmaceuticals
AGIO
#3421
Rank
A$5.11 B
Marketcap
$89.69
Share price
7.23%
Change (1 day)
167.12%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2024 (TTM): -A$0.6 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are A$29.4 Million. In 2023 the company made an earning of -A$0.6 Billion a decrease over its 2022 earnings that were of -A$0.6 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.6 Billion0.22%
2023 -A$0.6 Billion0.63%
2022 -A$0.6 Billion2.81%
2021 -A$0.58 Billion10.58%
2020 -A$0.52 Billion-18.41%
2019 -A$0.64 Billion15.72%
2018 -A$0.56 Billion12.99%
2017 -A$0.49 Billion59.61%
2016 -A$0.31 Billion69.32%
2015 -A$0.19 Billion119.28%
2014 -A$82.21 Million39.22%
2013 -A$59.05 Million69.1%
2012 -A$34.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.27 Billion-55.79%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.91 B-252.67%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$1.85 Billion 208.44%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.59 B-199.62%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.33 B-1,161.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$15.41 B-2,683.18%๐Ÿ‡บ๐Ÿ‡ธ USA